Back to Stocks

AMN

AMN HEALTHCARE SERVICES INC
7 filings tracked
healthcarehealthcare staffingMID ($2B-10B)

Company Intelligence Hub

Filing history, signal momentum, and bull/bear evolution

Chronological Filing Evolution (Click to filter / toggle)

Thesis (Bull Case Evolution)

AMN Healthcare has delivered a transformative first quarter, characterized by a staggering 100% year-over-year revenue increase to $1.38 billion. This growth was primarily fueled by a surge in labor disruption staffing, which contributed $683 million in incremental revenue.…

Bullish Outlook

Antithesis (Bear Case / Structural Risks)

Despite the headline growth, the bear case suggests that AMN's current success is a temporary mirage built on unpredictable labor unrest. The $683 million in incremental revenue is tied to one-off union strikes and is not a recurring stream.…

Risk Factors

Read the full bull/bear analysis

You are reading the free preview. Start a free trial to unlock the complete bull & bear analysis for every AMN filing.

Start Free Trial

Synthesis (Verdict & Resolution)

The Q1 2026 filing presents a company at a crossroads between structural growth and tactical windfalls. The massive revenue spike proves AMN's ability to mobilize resources rapidly during crises, but it masks a continuing decline in its steady-state technology and physician staffing businesses. The immediate financial impact is overwhelmingly positive, with a significant boost to liquidity and a return to profitability. However, the sustainability of this trajectory depends on whether AMN can convert its 'disruption' expertise into a permanent competitive advantage or if it remains a mere beneficiary of external chaos. Investors must weigh the impressive cash generation and operating leverage against the risk of a 'revenue cliff' as labor disputes resolve. The upcoming reconciliation of client deposits in the second and third quarters will be the critical litmus test for the quality of this quarter's earnings.

Selected Quarter

Core Takeaway

AMN has successfully capitalized on healthcare labor strikes to drive record short-term revenue and cash flow, though the sustainability of this growth is questionable.

Investor Lens

The trade-off is between immediate, massive cash generation and the long-term organic decline of the core SaaS and physician business.

Watch Next

The reconciliation of labor disruption deposits and settlements expected in Q3 2026.

View Full SEC Report

Signal Momentum Chart

Quarterly net bull/bear signal ratio. Click nodes to select a quarter.

BULLISH (+1.0)NEUTRAL (0.0)BEARISH (-1.0)+0.30Q2 '26 (10-Q)

Signal Timeline

Active Filters:Quarter: Q2 '26 (10-Q)
bullishMay 8

Revenue jumped 100% YoY driven by labor disruption staffing.

earnings beat
90%
bullishMay 8

SG&A as a percentage of revenue dropped from 21.4% to 15.8%.

margin expansion
70%
bearishMay 8

Consolidated gross margins declined from 28.7% to 26.8%.

margin compression
40%
neutralMay 8

Completed sale of Smart Square scheduling software.

divestiture
30%
bullishMay 8

Revenue jumped 100% YoY driven by labor disruption staffing.

earnings beat
90%
bullishMay 8

SG&A as a percentage of revenue dropped from 21.4% to 15.8%.

margin expansion
70%
bearishMay 8

Consolidated gross margins declined from 28.7% to 26.8%.

margin compression
40%
neutralMay 8

Completed sale of Smart Square scheduling software.

divestiture
30%
bullishMay 8

Revenue jumped 100% YoY driven by labor disruption staffing.

earnings beat
90%
bullishMay 8

SG&A as a percentage of revenue dropped from 21.4% to 15.8%.

margin expansion
70%
bearishMay 8

Consolidated gross margins declined from 28.7% to 26.8%.

margin compression
40%
neutralMay 8

Completed sale of Smart Square scheduling software.

divestiture
30%
bullishMay 8

Revenue jumped 100% YoY driven by labor disruption staffing.

earnings beat
90%
bullishMay 8

SG&A as a percentage of revenue dropped from 21.4% to 15.8%.

margin expansion
70%
bearishMay 8

Consolidated gross margins declined from 28.7% to 26.8%.

margin compression
40%
neutralMay 8

Completed sale of Smart Square scheduling software.

divestiture
30%
bullishMay 8

Revenue jumped 100% YoY driven by labor disruption staffing.

earnings beat
90%
bullishMay 8

SG&A as a percentage of revenue dropped from 21.4% to 15.8%.

margin expansion
70%
bearishMay 8

Consolidated gross margins declined from 28.7% to 26.8%.

margin compression
40%
neutralMay 8

Completed sale of Smart Square scheduling software.

divestiture
30%
bullishMay 8

Revenue jumped 100% YoY driven by labor disruption staffing.

earnings beat
90%
bullishMay 8

SG&A as a percentage of revenue dropped from 21.4% to 15.8%.

margin expansion
70%
bearishMay 8

Consolidated gross margins declined from 28.7% to 26.8%.

margin compression
40%
neutralMay 8

Completed sale of Smart Square scheduling software.

divestiture
30%
bullishMay 8

Revenue jumped 100% YoY driven by labor disruption staffing.

earnings beat
90%
bullishMay 8

SG&A as a percentage of revenue dropped from 21.4% to 15.8%.

margin expansion
70%
bearishMay 8

Consolidated gross margins declined from 28.7% to 26.8%.

margin compression
40%
neutralMay 8

Completed sale of Smart Square scheduling software.

divestiture
30%

Filing History

10-QMay 8, 2026
Expand Sequence

The Q1 2026 filing presents a company at a crossroads between structural growth and tactical windfalls. The massive revenue spike proves AMN's ability to mobilize resources rapidly during crises, but it masks a continuing decline in its steady-state technology and physician staffing businesses. The immediate financial impact is overwhelmingly positive, with a significant boost to liquidity and a return to profitability. However, the sustainability of this trajectory depends on whether AMN can convert its 'disruption' expertise into a permanent competitive advantage or if it remains a mere beneficiary of external chaos. Investors must weigh the impressive cash generation and operating leverage against the risk of a 'revenue cliff' as labor disputes resolve. The upcoming reconciliation of client deposits in the second and third quarters will be the critical litmus test for the quality of this quarter's earnings.

Disclaimer: The synthesis provided is generated by AI models and should not be construed as investment advice. Analysis is based solely on regulatory data present at the time of publication. Consult a financial advisor for specific investment strategies.